Table 5.
Reasons for discontinuing medication given in % of treatment episodes.
| No effect (%) | Side effects (%) | No reason given (%) | N | |
|---|---|---|---|---|
| Amitriptyline | 42.3 | 57.7 | 8.8 | 57 |
| NSAIDs | 83.7 | 16.3 | 7.5 | 53 |
| SNRI | 42.4 | 57.6 | 0 | 33 |
| Pregabalin | 48.3 | 51.7 | 0 | 29 |
| Weak opioids | 74.1 | 25.9 | 0 | 27 |
| Metamizole | 57.1 | 28.6 | 14.3 | 14 |
| Flupirtine | 84.6 | 7.7 | 7.7 | 13 |
| Acetaminophen | 100.0 | 0.0 | 0 | 12 |
| SSRI | 81.8 | 18.2 | 0 | 11 |
| Strong opioids | 60.0 | 40.0 | 0 | 5 |
| COX-2 inhibitors | 100.0 | 0.0 | 0 | 2 |
| Cyclobenzaprine | 33.3 | 33.3 | 33.3 | 3 |
| Corticosteroids | 100.0 | 0.0 | 0 | 1 |
| Lidocaine | 100.0 | 0.0 | 0 | 1 |
| All | 60.1 | 34.1 | 5.8 | 261 |
N, the total number of treatments with the respective drug in the past.